Authors: Claesson, K Brattstrom, C Burke, JT

Citation: K. Claesson et al., Sirolimus and erythromycin interaction: Two cases, TRANSPLAN P, 33(3), 2001, pp. 2136-2136

Authors: Johnson, RWG Kreis, H Oberbauer, R Brattstrom, C Claesson, K Eris, J

Citation: Rwg. Johnson et al., Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure., TRANSPLANT, 72(5), 2001, pp. 777-786

Authors: Squifflet, JP Backman, L Claesson, K Dietl, KH Ekberg, H Forsythe, JLR Kunzendorf, U Heemann, U Land, W Morales, JM Muhlbacher, F Talbot, D Taube, D Tyden, G van Hooff, J Schleibner, S Vanrenterghem, Y

Citation: Jp. Squifflet et al., Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients, TRANSPLANT, 72(1), 2001, pp. 63-69

Authors: Eriksson, BM Sjolin, J Claesson, K Wirgart, BZ Grillner, L Totterman, TH

Citation: Bm. Eriksson et al., Circulating soluble vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in immunocompetent and renal transplant patients: Correlation with cytomegalovirus disease and renal function, SC J IN DIS, 33(5), 2001, pp. 350-354

Authors: Groth, CG Backman, L Morales, JM Calne, R Kreis, H Lang, P Touraine, JL Claesson, K Campistol, JM Durand, D Wramner, L Brattstrom, C Charpentier, B

Citation: Cg. Groth et al., Sirolimus (rapamycin)-based therapy in human renal transplantation - Similar efficacy and different toxicity compared with cyclosporine, TRANSPLANT, 67(7), 1999, pp. 1036-1042

Authors: Groth, CG Brattstrom, C Claesson, K Backman, L

Citation: Cg. Groth et al., New trails in transplantation: How to exploit the potential of sirolimus in clinical transplantation, TRANSPLAN P, 30(8), 1998, pp. 4064-4065